|
References
Arruzazabala, M.L. et al.. Comparative study of policosanol, aspirin
and the combination therapy policosanol-aspirin on platelet aggregation
in healthy volunteers. Pharmacol. Res. 1997; 36:293-7.
Stusser, R. et al. Long-term therapy with policosanol improves
treadmill exercise-ECG testing performance of coronary heart disease
patients. Int. J. Clin. Pharmacol. Ther. 1998; 36:469-73.
Carbajal, D. et al. Effect of policosanol on platelet aggregation
and serum levels of arachidonic acid metabolites in healthy volunteers.
Prost. Leuk. Essen. Fatty Acids 1998; 58:61-4.
Lindstedt, L. et al. Matrix metalloproteinases-3, -7, and -12, but
not -9, reduce high density lipoprotein-induced cholesterol efflux from
human macrophage foam cells by truncation of carboxyl terminus of
apolipoprotein A-I. Parallel losses of pre-beta particles and the high
affinity component of efflux. J. Biol. Chem. 1999; 274:22627-34.
Mas, R. et al. Effects of policosanol in patients with type II
hypercholetserolemia and additional coronary risk factors. Clin.
Pharmacol. Ther. 1999; 65:439-47.
Menendez, R. et al. Oral administration of policosanol inhibits in
vitro copper ion-induced rat lipoprotein peroxidation. Physiol. Behav.
1999; 67:1-7.
Negre-Aminou, P. et al. Antiproliferative potencies of 6 vastatins
in cultured human cells: involvement of the ras-mediated signalling
pathway. Presented at the 66th Congress of the European Atherosclerosis
Society 1996; July 13-17, Florence): 120.
Noa, M. et al. Effect of policosanol on lipofundin-induced
atherosclerotic lesions in rats. J. Pharm. Pharmacol. 1995; 47:289-91.
Noa, M. et al. Effect of policosanol on foam-cell formation in
carrageenan-induced granulomas in rats. J. Pharm. Pharmacol. 1996;
48:282-5.
Noa, M. et al. Effect of olicosanol on damaged arterial wall induced
by forceps in rabbits. J. Electron. Microsc. 1998; 4:629-30.
Xu, X.P. et al. Oxidized low-density lipoprotein regulates matrix
metalloproteinase-9 and its tissue inhibitor in human monocyte-derive
macrophages. Circulation 1999; 99:993-8. | 
Print
PDF
Email
View Health Concern
